Cantor Fitzgerald upgraded Gilead (GILD) to Overweight from Neutral with a price target of $125, up from $100, as the analyst took over coverage of the stock.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GILD:
- Gilead reports ASCENT-04/KEYNOTE-D19 study met primary endpoint
- Gilead ASCENT-04 data a ‘welcome surprise,’ says Oppenheimer
- Options Volatility and Implied Earnings Moves This Week, April 21 – April 25, 2025
- Gilead Sciences: Strong Financial Outlook and Strategic Positioning Justify Buy Rating
- JPMorgan CEO Jamie Dimon Warns U.S. Has No “Divine Right to Success” Under Tariffs